Friday 6 November 2026 Export WAT’s income statement to Excel — free account

Waters Corporation

WAT Healthcare Diagnostics & Research

Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024.

Revenue: +120.9%
EPS: −67.0%
Free cash flow: −66.7%
Total debt: +308.2%

Quarter to September 2026, against a year earlier

460.91 7.83 +1.73%

Follow WAT

Alert me

Market cap: $44.5B
P/E: 194×
Fwd P/E: 81.0×
Dividend yield: —
F-score: 5/9
Altman Z: 9.63
Beneish M: −2.37
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Waters Corporation 8-K filed Aug 21, 2026

Period ended Aug 17, 2026 · Filed Aug 21, 2026 · accepted 9:20 AM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers; 8.01 Other events

Red flags

Officer departure Aug 21, 2026
Waters Corporation reported the departure of an officer or director

8-K filed Aug 21, 2026 · The filing · sec.gov